SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
October 30, 2012
ST. LOUIS, -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), has signed an agreement with Seoul, South Korea-based CrystalGenomics to support the development of active pharmaceutical ingredients (APIs) for next-generation non-steroidal anti-inflammatory drugs (NSAID). The agreement represents SAFC's premier pre-formulation services contract into the growing South [...]
Laser etched alphanumeric coded tubes
October 30, 2012
Micronic has introduced a range of laser etched alphanumeric coded sample storage tubes (0.5ml, 0.75ml, 1.1ml and 1.4ml). The new tubes have a flat polypropylene bottom on which the alphanumeric code is encrypted with a laser. Uniquely manufactured from a single component - the code of Micronic laser encrypted alphanumeric codes cannot fade or peel [...]
October 30, 2012
NEWARK, Calif., -- StemCells, Inc. (Nasdaq:STEM) announced today that it has partnered with R Biomedical, an Edinburgh, UK-based biomedical company, to develop and commercialize a range of cell lines and reagents to facilitate human induced pluripotent stem (iPS) cell-based research for regenerative medicine applications. The first product under the partnership, an "ultra-primary" human fibroblast cell [...]
Jacob Belson appointed as CEO of Modcon Systems Ltd (Israel)
October 30, 2012
(Akko, Israel) - Jacob Belson, COO of Modcon Systems Ltd, has been named corporate vice president and chief executive officer for Modcon Systems operation in Israel. Jacob Belson will assume his role effective November 1, 2012. Jacob Belson holds B.Sc. in industrial management engineering, MBA in business administration and M.A in business coaching. He has [...]
Tecan and TAP Biosystems to automate RAFT™ 3D cell culture using Freedom EVO® system
October 30, 2012
Tecan and TAP Biosystems, a leading supplier of innovative cell culture systems, have announced a co¬marketing agreement to further expand the automated 3D cell culture capabilities of the Freedom EVO® liquid handling platform. Automation of TAP’s collagen-based RAFT™ cell culture system will allow scientists to quickly and conveniently create 3D cell cultures in a 96-well, [...]
Bio-Rad Acquires Cell Sorting System From Propel Labs
October 30, 2012
HERCULES, CA -- Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products today announced that they have acquired a new cell sorting system from Propel Labs. Under the terms of agreement, Bio-Rad has acquired an automated, easy-to-use benchtop sorting flow cytometer. The instrument [...]
Aspera expands its EMEA Operations to Support Triple-Digit Growth
October 30, 2012
EMERYVILLE, Calif -- High-speed file transfer innovator expands EMEA team to drive European expansion. On the back of unprecedented triple-digit growth, Aspera, Inc. (https://www.asperasoft.com/), creator of patented fasp™ transport technology that moves the world’s digital assets at maximum speed, has announced a series of strategic appointments to support further EMEA expansion across a range of [...]
Luminex Corporation Reports Third Quarter 2012 Results
October 29, 2012
AUSTIN, Texas, -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2012. Financial and operating highlights include the following: • Completed the acquisition of GenturaDx, Inc., effective July 11, 2012. Integration activities are on-track • Consolidated third quarter revenue of $50.0 million, a 10 percent increase over the third [...]
Interim report for the period January – September 2012
October 29, 2012
Third quarter July - September 2012 • Group net sales in the third quarter 2012 increased by 1 percent to 107.1 MSEK (106.6). At comparable exchange rates the sales were at the same level as the corresponding quarter 2011. • Operating profit in the quarter amounted to 8.9 MSEK (10.9). • The result after tax [...]
BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
October 29, 2012
BOTHELL, Wash., -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced the Company's novel biopreservation technology is being used in more than 50 clinical trial-stage cellular therapies, making it the leading [...]

